Medicine composition for treating hepatic cirrhosis, and application thereof

Abstract

A medicine composition for treating hepatic cirrhosis comprises the following active pharmaceutical ingredients: radix paeoniae alba, radix sanguisorbae, rhizoma curcumae, dragon's blood, corydalis tuber, giant knotweed, grossy privet fruit, wild buckwheat, tall gastrodis tuber, szechuan lovage rhizome, herba artemisiae scopariae, selfheal, herba taraxaci, akebiaquinata, rhizoma imperatae, radix gentianae macrophyllae,erythrina indica, holly root, rhizoma sparganii, safflower, buddleja asiatica, longhairy antenoron herb, piper hancei Maxim., kadsura pepper stem, endothelium corneum gigeriae galli, barbed skullcap herb, panax notoginseng, spreading hedyotis herb, common leafflower herb, agastache and herba gynostemmatis pentaphylli. The pharmaceutical ingredients of the composition provided by the invention are synergistic with one another to realize efficiencies of clearing heat to remove toxicity, soothing liver to smooth qi, and promoting blood circulation to remove blood stasis, and the medicine composition has an obvious effect of improving the life quality of patients suffering from hepatic cirrhosis.

Description

technical field [0001] The invention belongs to the technical field of medicine and relates to a traditional Chinese medicine composition, in particular to a medicinal composition for treating liver cirrhosis and its application. Background technique [0002] Liver cirrhosis (hepatic cirrhosis) is a common clinical chronic progressive liver disease, which is diffuse liver damage caused by long-term or repeated effects of one or more causes. In my country, most of them are post-hepatitis cirrhosis, and a small part are alcoholic cirrhosis and schistosome cirrhosis. Histopathologically, extensive liver cell necrosis, nodular regeneration of residual liver cells, connective tissue hyperplasia, and fibrous septum formation lead to structural destruction of hepatic lobules and formation of pseudolobules. The liver gradually deforms and hardens and develops into cirrhosis. In the early stage, there are no obvious symptoms due to the strong compensatory function of the liver. In t...

AI Technical Summary

Problems solved by technology

[0007] 2. Decompensation period (generally belongs to Child-Pugh B, C level)

It can be seen that although the above conventional prescriptions for the treatment of chronic liver diseases can widely treat common chronic liver diseases, for the treatment of liver cirrhosis, there are problems of slow onset of effect and poor pertinence